Which returned more over the last year, BSV or IBB?

In the year to Sep 12, 2026, with distributions reinvested, BSV returned +1.1% and IBB returned +41.5%, so IBB returned more. One year is one year; the longer windows are in the table.

Which is cheaper, BSV or IBB?

BSV charges 0.03% a year and IBB charges 0.44%, so BSV is cheaper. Fees come from each fund's prospectus.

Data as of Sep 12, 2026. Both funds on the fields they both publish, from the same sources.

ETFIQetfiq.com · independent ETF data

BSV vs IBB: how they differ

BSV and IBB hold 0% of their weight in the same names, and IBB returned more over the year.

Vanguard Short-Term Bond Index Fund and iShares Biotechnology ETF.

What they hold in common

By the books each fund has filed, BSV and IBB hold 0% of their money in the same securities at the same weight.

Largest positions each one holds and the other does not
Only in BSV	Only in IBB
United States Treasury Note/Bond 1.13%	Vertex Pharmaceuticals, Inc. 8.09%
United States Treasury Note/Bond 0.90%	Amgen, Inc. 7.84%
United States Treasury Note/Bond 0.89%	Gilead Sciences, Inc. 6.85%
United States Treasury Note/Bond 0.82%	Regeneron Pharmaceuticals, Inc. 4.91%
United States Treasury Note/Bond 0.81%	Argenx SE 3.76%
United States Treasury Note/Bond 0.81%	Alnylam Pharmaceuticals, Inc. 3.12%
United States Treasury Note/Bond 0.80%	Natera, Inc. 2.89%
United States Treasury Note/Bond 0.78%	Revolution Medicines, Inc. 2.78%

Weight overlap is an ETFIQ calculation: for every security both funds hold, the smaller of the two weights, summed. Above 50%, holding both is close to holding one of them twice. Holdings dated Jun 30, 2026.

BSV and IBB on the fields both publish, as of Sep 12, 2026. Source: ETFIQ.
	BSV Vanguard Short-Term Bond Index Fund	IBB iShares Biotechnology ETF
Where it sits	Core index fund	Core index fund
Issuer	Vanguard	iShares
What it is	Short-Term Bond	Biotechnology
Total return, 1 year	+1.1%	+41.5%
S&P 500 over the same days	+17.5%	+17.5%
Gap to the S&P 500	−16.4 pts	+24.0 pts
Expense ratio	0.03%	0.44%
Holdings	3185	248

BSV in plain words

BSV is a bond fund tracking the Short-Term Bond. Over the year to Sep 11, 2026 it returned +1.1% with distributions reinvested, against +17.5% for the S&P 500 and +23.0% for the Nasdaq-100. The prospectus expense ratio is 0.03% a year.

IBB in plain words

IBB is an index equity fund tracking the Biotechnology. Over the year to Sep 11, 2026 it returned +41.5% with distributions reinvested, against +17.5% for the S&P 500 and +23.0% for the Nasdaq-100. The prospectus expense ratio is 0.44% a year. By its holdings filed for Jun 30, 2026, 36% of the fund by weight is stocks the S&P 500 also holds, across 248 positions, with the top ten at 44.8%. It sat 6.5% below its high of Aug 19, 2026 on Sep 11, 2026.

Questions people ask

Which returned more over the last year, BSV or IBB?: In the year to Sep 12, 2026, with distributions reinvested, BSV returned +1.1% and IBB returned +41.5%, so IBB returned more. One year is one year; the longer windows are in the table.
Which is cheaper, BSV or IBB?: BSV charges 0.03% a year and IBB charges 0.44%, so BSV is cheaper. Fees come from each fund's prospectus.

Other comparisons

Where to next

Where these figures came from

ETFIQ links to the documents behind every figure. It is not affiliated with any issuer, and a link is not an endorsement.

BSV against IBB, ETFIQ, data as of Sep 12, 2026. Every figure is arithmetic on a named public source; the method is at etfiq.com/methodology. A comparison is not a recommendation.

Cite this page. ETFIQ, BSV against IBB, data as of Sep 12, 2026. https://etfiq.com/compare/any/BSV-IBB Free to use with attribution; the underlying files are at Open data.

A comparison is not a recommendation. Standards and sources